Suboptimal response to imatinib according to 2006-2009 European LeukaemiaNet criteria: a 'grey zone' at 3, 6 and 12 months identifies chronic myeloid leukaemia patients who need early intervention.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples